Rafael Moreno-Luna1,2, Rocio Muñoz-Hernandez2, Ruei-Zeng Lin1, Maria L Miranda2, Antonio J Vallejo-Vaz2, Pablo Stiefel2, Juan M Praena-Fernández3, Jose Bernal-Bermejo4, Luis M Jimenez-Jimenez5, Jose Villar2, Juan M Melero-Martin1. 1. Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA. 2. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Unidad Clínico-Experimental de Riesgo Vascular (UCAMI-UCERV), Seville, Spain. 3. Unidad de Asesoría Estadística, Metodología y Evaluación de Investigación. Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI). Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. 4. Unidad de Gestión Clínica de Ginecología Obstetricia y Patologías Mamarias del Hospital de la Mujer, Hospital Universitario Virgen del Rocío, Seville, Spain. 5. Servicio de Bioquímica Clínica, Hospital Universitario Virgen del Rocío, Seville, Spain.
Abstract
OBJECTIVE: Endothelial colony-forming cells (ECFCs) are a subset of circulating endothelial progenitor cells that are particularly abundant in umbilical cord blood. We sought to determine whether ECFC abundance in cord blood is associated with maternal body-mass index (BMI) in nonpathologic pregnancies. STUDY DESIGN: We measured the level of ECFCs in the cord blood of neonates (n = 27) born from non-obese healthy mothers with nonpathologic pregnancies and examined whether ECFC abundance correlated with maternal BMI. We also examined the effect of maternal BMI on ECFC phenotype and function using angiogenic and vasculogenic assays. RESULTS: We observed variation in ECFC abundance among subjects and found a positive correlation between prepregnancy maternal BMI and ECFC content (r = 0.51, P = .007), which was independent of other obstetric factors. Despite this variation, ECFC phenotype and functionality were deemed normal and highly similar between subjects with maternal BMI <25 kg/m(2) and BMI between 25-30 kg/m(2), including the ability to form vascular networks in vivo. CONCLUSIONS: This study underlines the need to consider maternal BMI as a potential confounding factor for cord blood levels of ECFCs in future comparative studies between healthy and pathologic pregnancies.
OBJECTIVE: Endothelial colony-forming cells (ECFCs) are a subset of circulating endothelial progenitor cells that are particularly abundant in umbilical cord blood. We sought to determine whether ECFC abundance in cord blood is associated with maternal body-mass index (BMI) in nonpathologic pregnancies. STUDY DESIGN: We measured the level of ECFCs in the cord blood of neonates (n = 27) born from non-obese healthy mothers with nonpathologic pregnancies and examined whether ECFC abundance correlated with maternal BMI. We also examined the effect of maternal BMI on ECFC phenotype and function using angiogenic and vasculogenic assays. RESULTS: We observed variation in ECFC abundance among subjects and found a positive correlation between prepregnancy maternal BMI and ECFC content (r = 0.51, P = .007), which was independent of other obstetric factors. Despite this variation, ECFC phenotype and functionality were deemed normal and highly similar between subjects with maternal BMI <25 kg/m(2) and BMI between 25-30 kg/m(2), including the ability to form vascular networks in vivo. CONCLUSIONS: This study underlines the need to consider maternal BMI as a potential confounding factor for cord blood levels of ECFCs in future comparative studies between healthy and pathologic pregnancies.
Authors: Dmitry O Traktuev; Daniel N Prater; Stephanie Merfeld-Clauss; Aravind Raj Sanjeevaiah; M Reza Saadatzadeh; Michael Murphy; Brian H Johnstone; David A Ingram; Keith L March Journal: Circ Res Date: 2009-05-14 Impact factor: 17.367
Authors: Xiaofang Chen; Anna S Aledia; Stephanie A Popson; Linda Him; Christopher C W Hughes; Steven C George Journal: Tissue Eng Part A Date: 2010-02 Impact factor: 3.845
Authors: Juan C Acosta; David M Haas; Chandan K Saha; Linda A Dimeglio; David A Ingram; Laura S Haneline Journal: Am J Obstet Gynecol Date: 2010-12-16 Impact factor: 8.661
Authors: Ruei-Zeng Lin; Alexandra Dreyzin; Kristie Aamodt; Andrew C Dudley; Juan M Melero-Martin Journal: Cell Transplant Date: 2010-09-30 Impact factor: 4.064
Authors: M Jawad Javed; Laura E Mead; Daniel Prater; Waylan K Bessler; David Foster; Jamie Case; W Scott Goebel; Mervin C Yoder; Laura S Haneline; David A Ingram Journal: Pediatr Res Date: 2008-07 Impact factor: 3.756
Authors: Christopher D Baker; Sharon L Ryan; David A Ingram; Gregory J Seedorf; Steven H Abman; Vivek Balasubramaniam Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: Abigail Fraser; Kate Tilling; Corrie Macdonald-Wallis; Naveed Sattar; Marie-Jo Brion; Li Benfield; Andy Ness; John Deanfield; Aroon Hingorani; Scott M Nelson; George Davey Smith; Debbie A Lawlor Journal: Circulation Date: 2010-06-01 Impact factor: 29.690
Authors: Rocio Muñoz-Hernandez; Maria L Miranda; Pablo Stiefel; Ruei-Zeng Lin; Juan M Praena-Fernández; Maria J Dominguez-Simeon; Jose Villar; Rafael Moreno-Luna; Juan M Melero-Martin Journal: Hypertension Date: 2014-04-21 Impact factor: 10.190
Authors: Ruei-Zeng Lin; Adam Hatch; Victor G Antontsev; Shashi K Murthy; Juan M Melero-Martin Journal: Tissue Eng Part C Methods Date: 2014-09-17 Impact factor: 3.056
Authors: Marta Rojas-Torres; Ismael Sánchez-Gomar; Antonio Rosal-Vela; Lucía Beltrán-Camacho; Sara Eslava-Alcón; José Ángel Alonso-Piñeiro; Javier Martín-Ramírez; Rafael Moreno-Luna; Mª Carmen Durán-Ruiz Journal: Stem Cell Res Ther Date: 2022-06-21 Impact factor: 8.079
Authors: Emily K Blue; BreAnn M Sheehan; Zia V Nuss; Frances A Boyle; Caleb M Hocutt; Cassandra R Gohn; Kaela M Varberg; Jeanette N McClintick; Laura S Haneline Journal: Diabetes Date: 2015-02-26 Impact factor: 9.461